Ndax is thrilled to announce staking for Injective Protocol's INJ token. As pioneers in the Canadian crypto investing landscape, we're continually striving to offer Ndax users access to the most innovative opportunities in this ever-evolving world... But first—a little refresher on injective:
Injective Protocol is a decentralized layer-1 blockchain designed for high-speed and low-cost trading, offering an innovative approach to financial markets. With a focus on enabling permissionless and decentralized finance (DeFi), Injective provides unique solutions for derivatives, spot trading, and cross-chain interoperability.
Injective stands out in the blockchain space with its proprietary technology stack, designed to optimize decentralized trading. It features a fully decentralized order book, which allows users to trade assets without relying on centralized intermediaries. This feature provides increased security and reduced counterparty risk. Injective also supports cross-chain interoperability, enabling the seamless exchange of assets between various blockchains without the need for centralized exchanges. Additionally, the protocol leverages a high-performance Tendermint-based consensus engine, offering near-instant transaction finality and scalability. It supports the creation and trading of complex financial instruments such as derivatives, options, and synthetic assets. Lastly, Injective’s gasless trading model ensures that users can trade without the concern of high transaction fees, making it an attractive choice for traders and developers alike.
As the native token of Injective Protocol, INJ plays a central role in the ecosystem’s governance, staking, and utility functions. It is used for staking on the network to secure the protocol and participate in consensus, enabling validators to process transactions and earn crypto rewards. INJ is also used for governance, allowing token holders to propose and vote on key decisions, ensuring a decentralized and community-driven development path. Finally, INJ serves as collateral for trading derivatives and other financial products, helping to facilitate liquidity across the platform. Users can also utilize INJ assets to pay for transaction fees and gain access to premium services and features within the Injective ecosystem.
Injective Protocol operates on a unique combination of a Layer-1 blockchain and a decentralized order book that facilitates fast, low-cost trading. The protocol uses a custom-built blockchain powered by the Cosmos SDK, which provides interoperability with other blockchains, enabling cross-chain decentralized exchanges (DEXs). This architecture allows for the creation of decentralized derivatives, futures, and synthetic assets that can be traded in a permissionless and trustless manner. The Injective network employs a Tendermint-based consensus algorithm, which ensures fast finality and high throughput, supporting thousands of transactions per second. Additionally, Injective’s decentralized trading infrastructure is coupled with an advanced Oracle network that supplies real-time market data, crucial for derivatives and synthetic asset trading. By decentralizing both the order book and trade execution, Injective ensures that users have complete control over their trades while benefiting from enhanced liquidity and minimal slippage.
Are you ready to tap into the potential of the Injective Protocol? Now you can put your crypto assets to work by participating in Injective staking. You can earn crypto rewards with up to 11% APY simply by staking your Injective assets and helping to secure and stabilize the network.
To get started trading or Staking INJ, log in today or visit What is Injective Protocol on Ndax to learn more.
Further Readings
Disclaimer: This article is not intended to provide investment, legal, accounting, tax, or any other advice and should not be relied on in that or any other regard. The information contained herein is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of cryptocurrencies or otherwise.